Page 3 - Best Breast cancer surgery doctors: TOP 54 doctors

Professor Abut Kebudi brings expertise in oncoplastic breast surgery from training at the European Breast Cancer Center in Germany.

• Specializes in oncological surgery with a focus on breast cancer
• Trained in laparoscopic and oncological surgery at UCLA
• Author of 250 scientific publications in the field
• Member of American College of Surgeons and European-Asian Breast Society

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

Dr. İlhami Soykan Barlas was born in the year 1977 in Istanbul Moda. He is graduated from Kadıköy Anadolu High School and Cerrahpaşa Faculty of Medicine. He was awarded the title of General Surgery Specialist after completing his general surgery specialization in Okmeydanı Training and Research Hospital in the year 2008. 

He went to Scotland 2 times in the years 2006-2007 and received advanced laparoscopic education. He awarded with ‘Certificate of Appreciation’ by the Ministry of Health of the Republic of Turkey in the year 2009 for his contributions to the establishment of Dr. Lütfi Kırdar Training and Research Hospital Burn Center and for his related works. 

After completing his compulsory service at Kastamonu İnebolu State Hospital between the years 2009-2011, resigned from his duty at the state owned institutions, returned to Istanbul and started to work in private sector. He has been working as kidney transplant and general surgery specialist in Florence Nightingale group of hospitals since the year 2013. Since the year 2017, he has been serving as academic Doctor Lecturer in Faculty of Medicine of Demiroğlu Science University. He has more than 20 articles published in national and international journals in general surgery and kidney transplant and more than 30 proceedings that are submitted in national and international congresses. 

He also has been the book editor and chapter author on kidney transplant and he also has been chapter author in various surgery books. Dr Soykan Barlas has been awarded the title ‘General Surgery Associate Professor’ in the year 2020. Currently, he has been working within the organization of Medical Park Group of Hospitals .

 EXPERIENCES 

 İstanbul Okmeydanı Training and Research Hospital 2003-2008 (Specialization Education ) 

 İstanbul Lütfi Kırdar Kartal Training and Research Hospital 2009 

 İnebolu State Hospital 2009-2011 (Compulsory Service Duty) 

 Private Hospitalium Şişli Hospital 2012-2013 

 Şişli Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2013-2020 

 Demiroğlu Science University Faculty of Medicine Surgery Department Lecturer 2017- Present 

 İstanbul Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2020- Present 

 Private Osmanoğlu Hospital Şişli 2020-2022 Medical Park Göztepe Hospital 2022- present.

SCIENTIFIC ARTICLES 

1.Soykan Barlas,ArzuAkan,YavuzEryavuz,GirayYavuz,SedatKamalı,Gülçin Kamalı: PrimaryHydatidosis of thegluteusmuscle:Report of a caseandreview of theliterature. Ind JSurg.2016; 78(2): 161–162. 

2.Metin Kement, Hakan Ahmet Acar, İlhami Soykan Barlas, Nihat Aksakal, Cem Gezen, Uygar Düzci, Mustafa Öncel: Clinical evaluation of a temporaryfecalcontainmentdevicefornonsurgicalfecaldiversion in perinealburns. Ulus Trauma Emergency Surgery Journal. 2011; 17(2): 123-127 

3.Bilgin Y, Hot S,BarlasIS,AkanA,Eryavuz Y:Short andlongtermresults of harmonicscalpelhemorrhoidectomyversusstaplerhemorrhoidopexy in treatment of hemorrhoidaldisease. Asian J Surg. 2015;38(4):214-9. 

4.Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T. NewOnsetDiabetesAfterKidneyTransplantationandPretransplantHypoma gnesemia.ProgTransplant. 2016 Mar;26(1):55-61. doi: 10.1177/1526924816633949. 

5.Sinangil A, Celik V, Barlas S, Altunrende F, Akin EB, Ecder T. CalcifiedDouble J StentafterSequentialLiverandRenalTransplantationAssociatedtoprim aryOxalosis: Case Report. BANTAO journal, 2015;13(2), 97-99. 

6.Sinangil A, Celik V, Barlas S, KuskuCabuk F, Akin EB, Ecder T. A veryraretumor in a renaltransplantdonorcandidate: primarymesentericneuroendocrinetumor.InternationalJournal Of AdvancesIn Case Reports, 2015;2(4):244-249 

7.Sinangil A, Celik V, Barlas S, Akin EB, Ecder T. Shouldtransplantureter be stentedroutinelyor not?EurRevMedPharmacolSci. 2014;18(23):3551-6. 

8.Sinangil A, Celik V, Barlas S, Koc Y, Basturk T, Sakaci T, Akin EB, Ecder T. Theincidence of newonsetdiabetesaftertransplantationandrelatedfactors: Singlecenterexperience. Nefrologia, 2017;37(2):181-188. 

9.Akin EB, Aydogdu I, Barlas IS. Introducing RobotAssistedLaparoscopicDonorNephrectomyAfterExperienceInHandAssistedRetroperitoneoscopicApproach. TransplantProceedings 2019;51, 2221-222. 

10. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Sardogan C, Akin EB. IncisionalComplicationsandCosmetic Evaluation AfterHand-AssistedRetroperitoneoscopicDonorNephrectomy. TransplantProceedings 2019; 51, 2215-2220. 

11. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Ecder T, Akin EB. HandAssistedNephretomyPredisposesIncisionalHerniationInObeseL ivingDonors. TransplantProceedings 2019; 51, 2210-2214. 

12.Sinangil A, Atan Ucar Z, KocY, Barlas IS, Abouzahir S,Ecder ST, Akin EB. TheOutcome of DesensitizationTherapy in Immunologically High-risk KidneyTransplantation: Single-Center Experience. TransplantProceedings 2019; 51, 2268-2273 

13.GodeOguten E, Barlas IS, Akin EB. MentalDistressSymptomsand Life SatisfactionamongLivingKidneyDonors: FrequencyandAssociationwithSubjectiveEvaluations. TransplantProceedings 2019; 51, 2232-2236 

14. Atan Ucar Z,Sinangil A, Koc Y, Barlas IS, AbouzahirS, Ecder T, Akin EB. TheClinicalPrognosis Of TheRenalRetransplantPatients: A Single Center Experience. TransplantProceedings 2019;51, 2274- 2278. 

15. Barlas IS, Demir M, Akın EB. A single-center nineyearexperience in pediatrickidneytransplantation. Cumhuriyet MedicalJournal 2020; 42 (1), 126-135

Known Expertise 

Medical Oncologist 

Academic Position 

Senior Lecturer 

Education

Bar-Ilan University, Israel / Computational Biology 

Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech 

Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics 

Semmelweis University/Doctor of Medicine 

Training and Specialization 

Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England 

Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center 

Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech 

Resident, Medical Oncology, TASMC, Israel 

6th year medical school rotations, Kaplan Medical Center, Israel 

Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US 

Clinical Experience 

Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative 

PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. 

PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. 

Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO 

Consultant on drugs and operations in the field of oncology, Leumit HMO 

Member of the Helsinki Committee for Clinical Studies, TASMC 

Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel 

Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society 

NGS interpretation clinic alongside head of pathology, TASMC, Israel 

PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel 

Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel

Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel 

Courses 

Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course 

Point-of-Care Ultrasound course, Israeli Medical Association 

GCP training Bioforum 

GCP training Bioforum

Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma 

Academic Experience 

Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University 

JIMS Journal Club - Instructor for students. 

Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. 

TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA 

Training team for oncology residents, TASMC, Israel 

Mentor for new intern, TASMC, Israel 

Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel 

Honors 

Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel

 Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel 

Sign of honor for reserve medical personnel for the battle in Lebanon, IDF

Completion of residency final examination (shlav Beit) with honors 

Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner 

Affiliations 

Israeli Medical Association (IMA) 

Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) 

The Israeli Lung Cancer Group (ILCG) 

European Society of Medical Oncology (ESMO) 

International Association for the Study of Lung Cancer (IASLC) 

The International Society of Liquid Biopsy (ISLB) 

The Israeli Society for Health-Tech 

Boards 

Co-founder, board member and treasurer of the Israeli Acute Oncology Society 

Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group 

Member of the Trustees of Oncology Innovation, TASMC, Israel 

Doctor of Medical Service IDF 

Areas of interest 

Thoracic malignancies, 

early to late phase clinical trials, 

intra-tumoral injections, 

comprehensive genomic profiling of tumors, 

liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; 

cell therapy

Dr. M Altan Kaya is a skilled surgeon. He specializes in gastric bypass, gastric sleeve, breast cancer surgery, and hemorrhoidectomy. He completed advanced training in minimally invasive surgery in Hamburg and Strasbourg. Dr. Kaya is dedicated to using the latest techniques to provide the best care for his patients.

He is a member of several respected surgical societies. These include the Turkish Surgical Association, the Society for Colorectal Tumor Surgery, and the European Society of Oncological Surgeons. Dr. Kaya has performed hundreds of complex surgeries. His work has helped improve patient outcomes and raise surgical standards in his field.

Experience

2017
Private Nisa Hospital

2011 - 2017
Yenibosna Private Ilke Hospital

2007 - 2011
Gaziosmanpaşa Private Bilge Hospital

Education

2005
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear, Nose, and Throat Diseases

2005
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear, Nose, and Throat Diseases

2000
İstanbul University Faculty of Medicine, Medical Education

2000
İstanbul University Faculty of Medicine, Medical Education

Dr. Séverine Iborra is the Chief Physician of the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen. Her responsibilities include obstetrics, the delivery room, the neonatal unit, and gynecology. The department also includes the Senology/Breast Clinic at the Bergisches Breast Center Solingen, led by Dr. Manuela Seifert.

Dr. Séverine Iborra is originally from France. She began her medical studies at the University of Lyon and later transferred to Albert-Ludwigs University in Freiburg, where she received her medical license in 2007. She earned her doctorate in 2008 for experimental research in molecular oncology. From August 2008 to November 2013, Dr. Iborra worked as a resident at the University Women’s Clinic in Freiburg. After passing her specialist exams in gynecology and obstetrics, she continued her career as a specialist at the same clinic. In November 2015, she moved to RWTH University Hospital Aachen as a senior physician.

At the Clinic for Gynecology and Obstetrics, under the leadership of Prof. Dr. E. Stickeler, Dr. Iborra led the obstetrics department from 2017 to 2019. Since December 2017, she was responsible for organizing education in the department, and in October 2019, she became the Managing Senior Physician and Personnel Senior Physician of the clinic, a position she held until she moved to Solingen.

In addition to her scientific work, with numerous publications and presentations at major gynecological conferences, Dr. Iborra deepened her medical specialties. She obtained certifications in oncological diagnostics and therapy from the Gynecological Oncology Working Group, as well as additional qualifications in Cervical Pathology and Colposcopy (AGCPC), Urogynecology and Pelvic Reconstructive Surgery (AGUP), and the Professional Association of Gynecologists (BVF).

In 2019, Dr. Iborra successfully completed further specialization in “Gynecological Oncology” and “Special Obstetrics and Perinatal Medicine.” She is an active member of leading German medical societies in her field, including the German Society for Gynecology and Obstetrics, the Cervical Pathology and Colposcopy Working Group, and the German Society for Prenatal and Birth Medicine.

Treatments Offered in Our Gynecology Department

• Hysteroscopy and Dilation and Curettage (D&C) for diagnostic and therapeutic purposes.
• Removal of abnormal or symptomatic ovarian findings, such as cysts, while preserving the remaining ovary.
• Oophorectomy (removal of ovaries) in cases of abnormalities or preventively when indicated.
• Myomectomy (removal of uterine fibroids) while preserving the uterus.
• Conservative treatment of fibroids: either medication or embolization performed by radiology specialists.
• Hysterectomy with or without removal of the cervix.
• Diagnosis and clarification of unclear findings in the cervix, vagina, and vulva.
• Dysplasia treatment.
• Endometriosis management.
• Cancer treatment for vulvar, vaginal, cervical, uterine, and ovarian cancers.
• Treatment for incontinence and/or pelvic organ prolapse.

Whenever possible, we offer all procedures as minimally invasive treatments using laparoscopy or the Da Vinci robotic system.

Chief Medical Doctor at one of Germany's top-ranked breast cancer centers – PD. Dr. Med. Scholz oversees 600+ surgeries yearly at Asklepios Barmbek Clinic.

• Leads Hamburg's busiest breast pathology center – 1 in 4 local patients treated here
• Specializes in modern surgical standards for breast cancer
• Five-time Focus magazine 'Top Clinic' award winner
• Performs 50+ surgeries monthly with her team

Recognized as a Surgeon of Excellence in Breast Treatment by the SRC, Dr. Filip specializes in advanced breast cancer surgeries at Ponderas Academic Hospital.

• Board-certified general surgeon with a focus on breast cancer treatment
• Offers a wide range of procedures from tumor excision to complex reconstructive surgeries
• Uses minimally invasive techniques for personalized patient care
• SRC-certified for excellence in breast treatment